Search Results - "Rowan, A. D."

Refine Results
  1. 1

    Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines by Koshy, P J, Henderson, N, Logan, C, Life, P F, Cawston, T E, Rowan, A D

    Published in Annals of the rheumatic diseases (01-08-2002)
    “…Objective: To investigate whether interleukin 17 (IL17), derived specifically from T cells, can promote type II collagen release from cartilage. The ability of…”
    Get full text
    Journal Article
  2. 2

    Differential Toll-like receptor-dependent collagenase expression in chondrocytes by Zhang, Q, Hui, W, Litherland, G J, Barter, M J, Davidson, R, Darrah, C, Donell, S T, Clark, I M, Cawston, T E, Robinson, J H, Rowan, A D, Young, D A

    Published in Annals of the rheumatic diseases (01-11-2008)
    “…To characterise the catabolic response of osteoarthritic chondrocytes to Toll-like receptor (TLR) ligands. Induction of the collagenases, matrix…”
    Get more information
    Journal Article
  3. 3

    Development of a novel 2D proteomics approach for the identification of proteins secreted by primary chondrocytes after stimulation by IL-1 and oncostatin M by CATTERALL, J. B, ROWAN, A. D, SARSFIELD, S, SAKLATVALA, J, WAIT, R, CAWSTON, T. E

    Published in Rheumatology (Oxford, England) (01-09-2006)
    “…To develop a proteomics approach to study changes in the secreted protein levels of primary human chondrocytes after stimulation by the pro-inflammatory…”
    Get full text
    Journal Article
  4. 4

    A Computer Simulation Approach to Assessing Therapeutic Intervention Points for the Prevention of Cytokine‐Induced Cartilage Breakdown by Proctor, C. J., Macdonald, C., Milner, J. M., Rowan, A. D., Cawston, T. E.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-04-2014)
    “…Objective To use a novel computational approach to examine the molecular pathways involved in cartilage breakdown and to use computer simulation to test…”
    Get full text
    Journal Article
  5. 5
  6. 6

    An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies by Vaidya, B., Pearce, S. H. S., Charlton, S., Marshall, N., Rowan, A. D., Griffiths, I. D., Kendall‐Taylor, P., Cawston, T. E., Young‐Min, S.

    Published in Rheumatology (Oxford, England) (01-02-2002)
    “…Objective. To examine the allelic association of the single nucleotide polymorphism (CTLA4A/G) in exon 1 of the cytotoxic T lymphocyte antigen‐4 (CTLA4) gene…”
    Get full text
    Journal Article
  7. 7

    Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1α by Hui, W, Rowan, A D, Cawston, T

    Published in Annals of the rheumatic diseases (01-03-2001)
    “…OBJECTIVE To investigate the effect of insulin-like growth factor 1 (IGF1) on the release of collagen, and the production and expression of matrix…”
    Get full text
    Journal Article
  8. 8

    Oncostatin M in combination with tumour necrosis factor α induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2 by Hui, W, Barksby, H E, Young, D A, Cawston, T E, McKie, N, Rowan, A D

    Published in Annals of the rheumatic diseases (01-11-2005)
    “…Objective: To determine whether oncostatin M (OSM) + tumour necrosis factor α (TNFα) induces aggrecanase activity in chondrocyte membranes, to determine the…”
    Get full text
    Journal Article
  9. 9

    Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography by Peake, N J, Foster, H E, Khawaja, K, Cawston, T E, Rowan, A D

    Published in Annals of the rheumatic diseases (01-04-2006)
    “…Objective: To measure gelatinase activities in paired synovial fluid (SF) and serum of patients with juvenile idiopathic arthritis (JIA), and to assess how…”
    Get full text
    Journal Article
  10. 10

    Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor by PEAKE, N. J, KHAWAJA, K, MYERS, A, NOWELL, M. A, JONES, S. A, ROWAN, A. D, CAWSTON, T. E, FOSTER, H. E

    Published in Rheumatology (Oxford, England) (01-12-2006)
    “…Interleukin-6 (IL-6) exerts multiple effects on chondrocytes and fibroblasts within the joint and is associated with disease activity in juvenile idiopathic…”
    Get full text
    Journal Article
  11. 11

    Transforming growth factor β1 and insulin-like growth factor 1 block collagen degradation induced by oncostatin M in combination with tumour necrosis factor α from bovine cartilage by Hui, W, Cawston, T, Rowan, A D

    Published in Annals of the rheumatic diseases (01-02-2003)
    “…Oncostatin M (OSM) in combination with tumour necrosis factor α (TNFα) promotes marked collagen breakdown from bovine cartilage in explant culture. This…”
    Get full text
    Journal Article
  12. 12

    Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor α by the release of collagen fragments via collagenases by Morgan, T G, Rowan, A D, Dickinson, S C, Jones, D, Hollander, A P, Deehan, D, Cawston, T E

    Published in Annals of the rheumatic diseases (01-02-2006)
    “…Background: The synergistic degradation of cartilage by oncostatin M (OSM) in combination with either interleukin 1 (IL1) or tumour necrosis factor α (TNFα)…”
    Get full text
    Journal Article
  13. 13

    Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes by Shingleton, W. D., Jones, D., Xu, X., Cawston, T. E., Rowan, A. D.

    Published in Rheumatology (Oxford, England) (01-08-2006)
    “…Objectives. Retinoic acid (RetA) and oncostatin M (OSM) have both been shown to mediate potent effects with respect to extracellular matrix integrity. This…”
    Get full text
    Journal Article
  14. 14

    Identification of the pathogenic pathways in osteoarthritic hip cartilage: commonality and discord between hip and knee OA by Xu, Y, Barter, M.J, Swan, D.C, Rankin, K.S, Rowan, A.D, Santibanez-Koref, M, Loughlin, J, Young, D.A

    Published in Osteoarthritis and cartilage (01-09-2012)
    “…Summary Objective To define for the first time the transcriptomes of normal and end-stage osteoarthritis (OA) hip cartilage. Materials and methods RNA was…”
    Get full text
    Journal Article
  15. 15

    Rat procathepsin B. Proteolytic processing to the mature form in vitro by ROWAN, A. D, MASON, P, MACH, L, MORT, J. S

    Published in The Journal of biological chemistry (05-08-1992)
    “…Expression of rat procathepsin B in yeast led to the secretion of both the latent and mature forms of the enzyme. Culture in the presence of a cysteine…”
    Get full text
    Journal Article
  16. 16

    Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines by Cleaver, C S, Rowan, A D, Cawston, T E

    Published in Annals of the rheumatic diseases (01-02-2001)
    “…OBJECTIVE To investigate whether interleukin 13 (IL13) could act in a chondroprotective manner and protect cartilage stimulated to resorb with a combination of…”
    Get full text
    Journal Article
  17. 17

    Process and controller performance monitoring: overview with industrial applications by Hoo, K. A., Piovoso, M. J., Schnelle, P. D., Rowan, D. A.

    “…Complex processes depend on regulatory control systems to operate. Changes made to the sensor system and the process itself as well as the natural degradation…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Esculetin inhibits cartilage resorption induced by interleukin 1α in combination with oncostatin M by Elliott, S, Rowan, A D, Carrère, S, Koshy, P, Catterall, J B, Cawston, T E

    Published in Annals of the rheumatic diseases (01-02-2001)
    “…OBJECTIVE To determine if a new inhibitor, esculetin (EST), can block resorption of cartilage. METHODS Interleukin 1α (IL1α, 0.04–5 ng/ml) and oncostatin M…”
    Get full text
    Journal Article
  20. 20

    Activation of procathepsin B in human hepatoma cells : the conversion into the mature enzyme relies on the action of cathepsin B itself by MACH, L, SCHWIHLA, H, STÜWE, K, ROWAN, A. D, MORT, J. S, GLÖSSL, J

    Published in Biochemical journal (15-07-1993)
    “…In order to elucidate the processing mechanism of the lysosomal cysteine proteinase, cathepsin B, in mammalian cells, recombinant rat and human cathepsin B…”
    Get full text
    Journal Article